Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Anhydrous Sodium Thiosulfate
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Anhydrous sodium thiosulfate Pedmarqsi
®
(80 mg/mL solution for infusion)
Malignant disease and immunosuppression, Drugs for cytotoxic-induced side-effects, 08.01
Links found
NICE TA1034: Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours